{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:56:50Z","timestamp":1781265410198,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In patients presenting with acute coronary syndrome (ACS) and multivessel disease, it is unclear whether non-culprit lesions should be revascularized immediately or in a staged procedure. We performed a meta-analysis of randomized controlled trials that compared immediate versus staged revascularization strategies. Two authors independently screened records from the online databases PubMed, Embase, Web of Science, and the Cochrane Library to identify eligible trials up to November 2025. The primary outcome was all-cause mortality at 1\u00a0year. Secondary outcomes included cardiovascular events at 1\u00a0year. Meta-regressions were performed to explore the influence of study-level characteristics. This study was registered in PROSPERO (CRD42023446181). Ten trials with a total of 5651 patients were included in the final analysis. All-cause death at 1\u00a0year occurred in 109 (3.9%) of 2809 patients in the immediate revascularization group and 100 (3.5%) of 2842 patients in the staged revascularization group (risk ratio, 1.10; 95% CI 0.79\u20131.52). Cardiovascular death at 1\u00a0year occurred in 76 (2.8%) of 2749 patients in the immediate revascularization group and 66 (2.4%) of 2768 patients in the staged revascularization group. Meta-regression suggested that higher mean patient age was significantly associated with a lower risk ratio favoring the immediate revascularization group (regression coefficient -0.10; 95% CI -0.16 to -0.002; p\u2009=\u20090.047). All-cause mortality and cardiovascular deaths were similar in patients with ACS, predominantly with STEMI, and multivessel coronary disease undergoing immediate or staged revascularization. The available effect estimates do not exclude the possibility of clinically meaningful benefit or harm from immediate revascularization.<\/jats:p>","DOI":"10.1007\/s11739-026-04369-z","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:48:18Z","timestamp":1778561298000},"page":"1469-1480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immediate versus staged revascularization in acute coronary syndrome and multivessel disease: a meta-analysis and meta-regression of RCTs"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-9036","authenticated-orcid":false,"given":"Felix","family":"Bergmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-5878","authenticated-orcid":false,"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Pecho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Stoiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Gelbenegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Pracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Leutzendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Heitzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta M.","family":"Siller-Matula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sch\u00f6rgenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-3953","authenticated-orcid":false,"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-1936","authenticated-orcid":false,"given":"Valentin","family":"al Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"18","key":"4369_CR1","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K et al (2018) Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 72(18):2231\u20132264","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4369_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ahj.2015.03.020","volume":"170","author":"LO Jensen","year":"2015","unstructured":"Jensen LO et al (2015) Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction. Am Heart J 170(1):70\u201378","journal-title":"Am Heart J"},{"issue":"16","key":"4369_CR3","first-page":"1571","volume":"382","author":"SR Mehta","year":"2020","unstructured":"Mehta SR, Wood DA, Cairns JA (2020) Complete revascularization with multivessel PCI for myocardial infarction. Reply. N Engl J Med 382(16):1571\u20131572","journal-title":"N Engl J Med"},{"issue":"12","key":"4369_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","volume":"369","author":"DS Wald","year":"2013","unstructured":"Wald DS et al (2013) Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 369(12):1115\u20131123","journal-title":"N Engl J Med"},{"issue":"9994","key":"4369_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","volume":"386","author":"T Engstrom","year":"2015","unstructured":"Engstrom T et al (2015) Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 386(9994):665\u2013671","journal-title":"Lancet"},{"issue":"25","key":"4369_CR6","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1016\/j.jacc.2019.10.033","volume":"74","author":"AH Gershlick","year":"2019","unstructured":"Gershlick AH et al (2019) Long-term follow-up of complete versus lesion-only revascularization in STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 74(25):3083\u20133094","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4369_CR7","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"M Writing Committee","year":"2022","unstructured":"Writing Committee M et al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. j Am Coll Cardiol 79(2):e21\u2013e129","journal-title":"j Am Coll Cardiol"},{"issue":"2","key":"4369_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119\u2013177","journal-title":"Eur Heart J"},{"issue":"14","key":"4369_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP et al (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289\u20131367","journal-title":"Eur Heart J"},{"key":"4369_CR10","doi-asserted-by":"publisher","first-page":"37203","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44:37203\u201337826","journal-title":"Eur Heart J"},{"issue":"7","key":"4369_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2011.03.046","volume":"58","author":"PJ Vlaar","year":"2011","unstructured":"Vlaar PJ et al (2011) Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 58(7):692\u2013703","journal-title":"J Am Coll Cardiol"},{"issue":"10507","key":"4369_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S0140-6736(25)01529-6","volume":"406","author":"MC Kim","year":"2025","unstructured":"Kim MC et al (2025) Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial. Lancet 406(10507):1032\u20131043","journal-title":"Lancet"},{"issue":"10383","key":"4369_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S0140-6736(23)00351-3","volume":"401","author":"R Diletti","year":"2023","unstructured":"Diletti R et al (2023) Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Lancet 401(10383):1172\u20131182","journal-title":"Lancet"},{"key":"4369_CR14","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa2307823","volume":"389","author":"BE Stahli","year":"2023","unstructured":"Stahli BE et al (2023) Timing of complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med 389:1368\u20131379","journal-title":"N Engl J Med"},{"key":"4369_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMoa2512918","volume":"394","author":"R Nijveldt","year":"2025","unstructured":"Nijveldt R et al (2025) Immediate or deferred nonculprit-lesion PCI in myocardial infarction. N Engl J Med 394:958\u2013968","journal-title":"N Engl J Med"},{"issue":"7454","key":"4369_CR16","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D et al (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490","journal-title":"BMJ"},{"issue":"2","key":"4369_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M et al (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97\u2013111","journal-title":"Res Synth Methods"},{"key":"4369_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ahj.2023.01.020","volume":"259","author":"S Park","year":"2023","unstructured":"Park S et al (2023) Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial. Am Heart J 259:58\u201367","journal-title":"Am Heart J"},{"issue":"3","key":"4369_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jacc.2015.10.082","volume":"67","author":"G Sardella","year":"2016","unstructured":"Sardella G et al (2016) Single-staged compared with multi-staged PCI in multivessel NSTEMI patients: the SMILE trial. J Am Coll Cardiol 67(3):264\u2013272","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"4369_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/hrt.2009.177162","volume":"96","author":"L Politi","year":"2010","unstructured":"Politi L et al (2010) A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart 96(9):662\u2013667","journal-title":"Heart"},{"key":"4369_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ehj.2011.08.030","volume":"63","author":"W Maamoun","year":"2011","unstructured":"Maamoun W, Elkhaeat N, Elarasy R (2011) Safety and feasibility of complete simultaneous revascularization during primary PCI in patients with STEMI and multi-vessel disease. Egypt Heart J 63:39\u201343","journal-title":"Egypt Heart J"},{"key":"4369_CR22","first-page":"57","volume":"9","author":"R Tarasov","year":"2017","unstructured":"Tarasov R et al (2017) Two preventive multivessel stenting strategy with zotarolimus eluting stents in ST-elevation myocardial infarction patients: 12-month results of randomized trial. Interv Cardiol 9:57\u201363","journal-title":"Interv Cardiol"},{"issue":"11","key":"4369_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.5152\/AnatolJCardiol.2021.71080","volume":"25","author":"MT Nichita-Brendea","year":"2021","unstructured":"Nichita-Brendea MT et al (2021) A clinical trial comparing complete revascularization at the time of primary percutaneous coronary intervention versus during the index hospital admission in patients with multi-vessel coronary artery disease and STEMI uncomplicated by cardiogenic shock. Anatol J Cardiol 25(11):781\u2013788","journal-title":"Anatol J Cardiol"},{"issue":"22","key":"4369_CR24","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","volume":"85","author":"SV Rao","year":"2025","unstructured":"Rao SV et al (2025) 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes. JACC 85(22):2135\u20132237","journal-title":"JACC"},{"key":"4369_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ahj.2025.04.007","volume":"287","author":"HJ Feistritzer","year":"2025","unstructured":"Feistritzer HJ et al (2025) Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease: design and rationale of the randomized COMPLETE-NSTEMI trial. Am Heart J 287:94\u2013106","journal-title":"Am Heart J"},{"key":"4369_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5707","volume":"341","author":"K Rahimi","year":"2010","unstructured":"Rahimi K et al (2010) Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review. BMJ 341:c5707","journal-title":"BMJ"},{"key":"4369_CR27","doi-asserted-by":"publisher","first-page":"1659184","DOI":"10.3389\/fcvm.2025.1659184","volume":"12","author":"R Jian","year":"2025","unstructured":"Jian R et al (2025) In-hospital mortality risk prediction models for patients with acute coronary syndrome: a systematic review and meta-analysis. Front Cardiovasc Med 12:1659184","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"4369_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1161\/CIRCINTERVENTIONS.109.928705","volume":"3","author":"C Johnman","year":"2010","unstructured":"Johnman C et al (2010) Percutaneous coronary intervention in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated between 2000 and 2007. Circ Cardiovasc Interv 3(4):341\u2013345","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"4369_CR29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/S0735-1097(02)01770-9","volume":"39","author":"RA Kerensky","year":"2002","unstructured":"Kerensky RA et al (2002) Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 39(9):1456\u20131463","journal-title":"J Am Coll Cardiol"},{"key":"4369_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.carrev.2021.03.019","volume":"35","author":"MM Balbi","year":"2022","unstructured":"Balbi MM et al (2022) Culprit lesion detection in patients presenting with Non-ST elevation acute coronary syndrome and multivessel disease. Cardiovasc Revasc Med 35:110\u2013118","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"4369_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.007305","volume":"12","author":"JF Heitner","year":"2019","unstructured":"Heitner JF et al (2019) Identifying the infarct-related artery in patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 12(5):e007305","journal-title":"Circ Cardiovasc Interv"},{"issue":"13","key":"4369_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJM200009283431303","volume":"343","author":"JA Goldstein","year":"2000","unstructured":"Goldstein JA et al (2000) Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343(13):915\u2013922","journal-title":"N Engl J Med"},{"key":"4369_CR33","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J Chandler","year":"2019","unstructured":"Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions. Wiley, Hoboken"},{"issue":"6","key":"4369_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jclinepi.2014.12.014","volume":"68","author":"PC Austin","year":"2015","unstructured":"Austin PC, Steyerberg EW (2015) The number of subjects per variable required in linear regression analyses. J Clin Epidemiol 68(6):627\u2013636","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"4369_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01310-0","volume":"21","author":"M Geissbuhler","year":"2021","unstructured":"Geissbuhler M et al (2021) Most published meta-regression analyses based on aggregate data suffer from methodological pitfalls: a meta-epidemiological study. BMC Med Res Methodol 21(1):123","journal-title":"BMC Med Res Methodol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04369-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04369-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04369-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:07:25Z","timestamp":1781262445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04369-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4369"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04369-z","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was a meta-analysis based exclusively on previously published data and did not involve direct participation of human subjects or animals. Therefore, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Statement"}},{"value":"For this type of study, informed consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}